Amanda McDowell

Talk of the Towne episode 06: XpertPatient

Talk of the Towne is a podcast from Antidote focused on that special place where science and patients converge. It’s hosted by Richard Towne, PharmD, Antidote’s Senior Clinical Informatics Manager. Each episode, Talk of the Towne features a new guest from an Antidote partner organization, and takes an in-depth look at particular therapeutic areas, zeroing in on the story that our data is telling ...

Continue reading

World Cancer Day cancer research roundup

The statistics about the prevalence of cancer can be disheartening. Over 10 million people die each year from cancer, making it one of the leading causes of death — and unfortunately, researchers have yet to find a cure for many cancers.

Continue reading

How we randomized 75 patients into a knee osteoarthritis clinical trial [case study]

Osteoarthritis (OA) is the most common type of arthritis that impacts the knee joint. It is a result of the knee cartilage progressively wearing away, which can lead to difficulty moving, stiffness, and weakness, all of which worsen with time. Knee OA makes up 80% of diagnosed osteoarthritis cases, impacting 19% of adults over the age of 45.

Continue reading

Antidote is attending SCOPE 2023

We’re always excited to get a chance to connect with people in the clinical trial industry, and this year, we’re thrilled to share that we’ll be attending SCOPE 2023 from February 6 to 9 in Orlando, Florida.

Continue reading

What causes osteoporosis?

Osteoporosis, translated directly to “porous bone,” is a condition that impacts approximately 10 million Americans. The human body is constantly producing bone cells, but they are constantly being lost as well — and when the cells are being dissolved faster than they are being produced, weakness can result. Below, we’ll be taking a closer look at what osteoporosis is, what causes it, and how ...

Continue reading

5 ways to increase diversity in your clinical trial

Increasing diversity, equity, and inclusion (DEI) in clinical trials is a topic that has received a lot of attention in recent years, especially on the heels of the most recent guidance from the Food and Drug Administration — but it is still an area ripe for improvement.

Continue reading

National Glaucoma Awareness Month: A Q&A with BrightFocus

National Glaucoma Awareness Month is a campaign aimed at increasing awareness around glaucoma, a leading cause of vision loss and blindness with no early warning signs.

Continue reading

5 hemophilia facts you might not know

Hemophilia is a disease in which the blood does not clot properly. It is rare and typically hereditary, often leading to spontaneous or excessive bleeding, especially following injuries or surgery, and internal bleeding can be a major risk factor. Below, we’re exploring a few hemophilia facts many people may not know.

Continue reading

The history of Alzheimer’s disease

Alzheimer’s disease is the most common type of dementia in the United States, impacting around 6.2 million people above the age of 65. Since it was first observed in the early 1900s, a lot of information has been uncovered through medical research.

Continue reading

How Antidote supports environmental sustainability [one-pager]

As a digital company, Antidote does not produce goods or services that have a major environmental impact — however, we understand that small changes still have a big impact.

Continue reading

Get our latest posts in your inbox